These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3691914)

  • 21. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Abbott F; Tron V
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgenetic alopecia: treatment results with topical minoxidil.
    Roberts JL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):705-10. PubMed ID: 3549805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.
    Pestana A; Olsen EA; Delong ER; Murray JC
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):971-6. PubMed ID: 3294945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
    Olsen EA; DeLong ER; Weiner MS
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):688-95. PubMed ID: 3549803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):737-44. PubMed ID: 3549810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
    Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
    J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
    Koperski JA; Orenberg EK; Wilkinson DI
    Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness.
    Rushton DH; Unger WP; Cotterill PC; Kingsley P; James KC
    Clin Exp Dermatol; 1989 Jan; 14(1):40-6. PubMed ID: 2680179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
    Hoedemaker C; van Egmond S; Sinclair R
    Australas J Dermatol; 2007 Feb; 48(1):43-5. PubMed ID: 17222303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical minoxidil in the treatment of male pattern alopecia.
    Kvedar JC; Baden HP
    Pharmacotherapy; 1987; 7(6):191-7. PubMed ID: 3328164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):730-6. PubMed ID: 3549809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response study of topical minoxidil in male pattern baldness.
    Olsen EA; DeLong ER; Weiner MS
    J Am Acad Dermatol; 1986 Jul; 15(1):30-7. PubMed ID: 3722507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.
    Berger RS; Fu JL; Smiles KA; Turner CB; Schnell BM; Werchowski KM; Lammers KM
    Br J Dermatol; 2003 Aug; 149(2):354-62. PubMed ID: 12932243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
    Gong L; Bao L; Tian T; Li Y
    J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.
    Mirmirani P; Consolo M; Oyetakin-White P; Baron E; Leahy P; Karnik P
    Br J Dermatol; 2015 Jun; 172(6):1555-1561. PubMed ID: 25204361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minoxidil: a comprehensive review.
    Gupta AK; Talukder M; Venkataraman M; Bamimore MA
    J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.